Zobrazeno 1 - 10
of 1 287
pro vyhledávání: '"Armando, Santoro"'
Autor:
Joel W. Neal, MD, PhD, Armando Santoro, MD, Maria Gonzalez-Cao, MD, PhD, Farah Louise Lim, MRCP, MD, Bruno Fang, MD, Ryan D. Gentzler, MD, MS, Jerome Goldschmidt, MD, Polina Khrizman, MD, Claudia Proto, MD, Shiven Patel, MD, MBA, FACP, Sonam Puri, MD, Stephen V. Liu, MD, Erminia Massarelli, MD, PhD, MS, Denise Williamson, MPH, Martin Schwickart, PhD, Christian Scheffold, MD, PhD, Svetlana Andrianova, MD, MPH, Enriqueta Felip, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 10, Pp 100666- (2024)
Introduction: We evaluated efficacy and safety of cabozantinib plus atezolizumab or cabozantinib alone in advanced NSCLC previously treated with an immune checkpoint inhibitor (ICI). Methods: COSMIC-021 (NCT03170960) is a phase 1b, multicenter study
Externí odkaz:
https://doaj.org/article/6812448f29344fa6a786793805d199c0
Autor:
Toshihiko Doi, David Tai, Dong-Wan Kim, F Stephen Hodi, Sofie Wilgenhof, Catherine Sabatos-Peyton, Giuseppe Curigliano, Chia-Chi Lin, Armando Santoro, Alexandros Xyrafas, Nicolas Mach, Sebastian Szpakowski, Shripad Chitnis, Sabine Gutzwiller, Alessandro Pastore
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Objective This study evaluates the safety/efficacy of sabatolimab plus spartalizumab in patients with melanoma or non-small cell lung cancer (NSCLC).Design, setting and participants This is a phase 1–1b/2, open-label, multinational, multicentre stu
Externí odkaz:
https://doaj.org/article/e226d4538acb4bd0bc0fcd5648207830
Autor:
Joaquina C. Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean‐Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose deMiguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F. Stephen Hodi
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 6, Pp n/a-n/a (2024)
Abstract SAR439459 (SAR'459), a “second‐generation” human anti‐transforming growth factor beta (TGFβ) monoclonal antibody, enhances the activity of immune checkpoint inhibitors. In this phase I/Ib study, we evaluated the safety, pharmacokine
Externí odkaz:
https://doaj.org/article/0d7ccfe237a8402d86c3353c80fd2923
Empowering beyond Pain: Pain Neuroscience Education Interventions in Breast Cancer Survivorship Care
Autor:
Marco Balordi, Paola Tiberio, Matteo Castaldo, Alessandro Viganò, Flavia Jacobs, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Publikováno v:
Cancers, Vol 16, Iss 16, p 2806 (2024)
Chronic pain is a common consequence of breast cancer (BC) and its treatments. Pain neuroscience education (PNE) is a non-pharmacological intervention that adopts a biopsychosocial approach and has already been proven to be effective for different ch
Externí odkaz:
https://doaj.org/article/946b91f616234a4fa932df5f2376c0f7
Autor:
Matteo Perrino, Emanuele Voulaz, Simone Balin, Gerardo Cazzato, Elena Fontana, Sara Franzese, Martina Defendi, Fabio De Vincenzo, Nadia Cordua, Roberto Tamma, Federica Borea, Marta Aliprandi, Marco Airoldi, Luigi Giovanni Cecchi, Roberta Fazio, Marco Alloisio, Giuseppe Marulli, Armando Santoro, Luca Di Tommaso, Giuseppe Ingravallo, Laura Russo, Giorgio Da Rin, Anna Villa, Silvia Della Bella, Paolo Andrea Zucali, Domenico Mavilio
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Thymic epithelial tumors (TETs) are rare mediastinal cancers originating from the thymus, classified in two main histotypes: thymoma and thymic carcinoma (TC). TETs affect a primary lymphoid organ playing a critical role in keeping T-cell homeostasis
Externí odkaz:
https://doaj.org/article/82ca357fe64d44e2bab8ed8d76fd1bce
Autor:
Armando Santoro, Eric Assenat, Thomas Yau, Jean-Pierre Delord, Michela Maur, Jennifer Knox, Stephane Cattan, Kyung-Hun Lee, Gianluca Del Conte, Christoph Springfeld, Elisa Leo, Alexandros Xyrafas, Lauren Fairchild, Feby Mardjuadi, Stephen L. Chan
Publikováno v:
JHEP Reports, Vol 6, Iss 4, Pp 101021- (2024)
Background & aims: This phase Ib/II trial evaluated the safety and efficacy of capmatinib in combination with spartalizumab or spartalizumab alone in patients with advanced hepatocellular carcinoma (HCC). Methods: Eligible patients who had progressed
Externí odkaz:
https://doaj.org/article/9e42ee62344d4ac28b99c8e6f48601dc
Autor:
Alexia Francesca Bertuzzi, Maria Susanna Grimaudo, Alice Laffi, Laura Giordano, Nicolò Gennaro, Umberto Cariboni, Licia Vanessa Siracusano, Vittorio Quagliuolo, Piergiuseppe Colombo, D’Orazio Federico, Salvatore Lorenzo Renne, Cristina Specchia, Ferdinando Cananzi, Andrea Marrari, Pierina Navarria, Primo Andrea Daolio, Stefano Bastoni, Armando Santoro
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 16254-16263 (2023)
Abstract Introduction The aim of this retrospective study was to investigate the clinicopathological characteristics of AYA sarcomas and their clinical outcomes at a high‐volume single center. Methods Demographic, clinicopathological data on the di
Externí odkaz:
https://doaj.org/article/7e41660ffae240f593090873594dd21e
Autor:
Paola Tiberio, Marco Balordi, Matteo Castaldo, Alessandro Viganò, Flavia Jacobs, Chiara Benvenuti, Rosalba Torrisi, Alberto Zambelli, Armando Santoro, Rita De Sanctis
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 7, p 711 (2024)
The treatment of early triple-negative breast cancer (eTNBC) has improved patients’ prognosis but often leads to adverse events and sequelae affecting quality of life (QoL). Pain Neuroscience Education (PNE) is a promising non-pharmacological inter
Externí odkaz:
https://doaj.org/article/f51351c8e6b244fc81074361b5737dd0
Autor:
Tiziana Comito, Maria Massaro, Maria Ausilia Teriaca, Ciro Franzese, Davide Franceschini, Pierina Navarria, Elena Clerici, Luciana Di Cristina, Anna Bertolini, Stefano Tomatis, Giacomo Reggiori, Andrea Bresolin, Silvia Bozzarelli, Lorenza Rimassa, Cristiana Bonifacio, Silvia Carrara, Armando Santoro, Alessandro Zerbi, Marta Scorsetti
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 7073-7088 (2023)
Aim: The gold standard of care for pancreatic adenocarcinoma is the integrated treatment of surgery and chemotherapy (ChT), but about 50% of patients present with unresectable disease. Our study evaluated the efficacy in terms of local control, survi
Externí odkaz:
https://doaj.org/article/22a190a815ca463fa09252c74656cc2a
Autor:
Agnese Losurdo, Angelo Dipasquale, Laura Giordano, Pasquale Persico, Elena Lorenzi, Antonio Di Muzio, Chiara Barigazzi, James Korolewicz, Aman Mehan, Oreoluwa Mohammed, Benhard Scheiner, David J. Pinato, Armando Santoro, Matteo Simonelli
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionIdentifying which patient may benefit from immunotherapeutic early-phase clinical trials is an unmet need in drug development. Among several proposed prognostic scores, none has been validated in patients receiving immunomodulating agents
Externí odkaz:
https://doaj.org/article/4be1b348b842416bbb7ac77a7e503688